Developing better digital health measures of Parkinson's disease using free living data and a crowdsourced data analysis challenge.
Journal
PLOS digital health
ISSN: 2767-3170
Titre abrégé: PLOS Digit Health
Pays: United States
ID NLM: 9918335064206676
Informations de publication
Date de publication:
Mar 2023
Mar 2023
Historique:
received:
21
09
2022
accepted:
07
02
2023
medline:
29
3
2023
entrez:
28
3
2023
pubmed:
29
3
2023
Statut:
epublish
Résumé
One of the promising opportunities of digital health is its potential to lead to more holistic understandings of diseases by interacting with the daily life of patients and through the collection of large amounts of real-world data. Validating and benchmarking indicators of disease severity in the home setting is difficult, however, given the large number of confounders present in the real world and the challenges in collecting ground truth data in the home. Here we leverage two datasets collected from patients with Parkinson's disease, which couples continuous wrist-worn accelerometer data with frequent symptom reports in the home setting, to develop digital biomarkers of symptom severity. Using these data, we performed a public benchmarking challenge in which participants were asked to build measures of severity across 3 symptoms (on/off medication, dyskinesia, and tremor). 42 teams participated and performance was improved over baseline models for each subchallenge. Additional ensemble modeling across submissions further improved performance, and the top models validated in a subset of patients whose symptoms were observed and rated by trained clinicians.
Identifiants
pubmed: 36976789
doi: 10.1371/journal.pdig.0000208
pii: PDIG-D-22-00272
pmc: PMC10047543
doi:
Types de publication
Journal Article
Langues
eng
Pagination
e0000208Informations de copyright
Copyright: © 2023 Sieberts et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Déclaration de conflit d'intérêts
I have read the journal’s policy and the authors of this manuscript have the following competing interests: YG serves as scientific advisor for Eli Lilly and Company and Merck & Co.; serves as scientific advisor and receives grants from Merck KGaA. YH has grant funding through BBJ from Sanofi S.A. and UCB for unrelated projects. BBJ has grant funding from Sanofi S.A. and UCB for unrelated projects. AJ is funded by MJ Fox Foundation for data curation. All other authors report no competing interests.
Références
J Parkinsons Dis. 2020;10(2):429-454
pubmed: 32250314
Sci Data. 2016 Mar 03;3:160011
pubmed: 26938265
Arch Neurol. 1989 Sep;46(9):955-9
pubmed: 2528339
Mov Disord. 2008 Nov 15;23(15):2129-70
pubmed: 19025984
Methods. 2016 Jan 15;93:92-102
pubmed: 26342255
Nat Biotechnol. 2022 Apr;40(4):480-487
pubmed: 34373643
NPJ Digit Med. 2019 Oct 11;2:99
pubmed: 31633058
JMIR Mhealth Uhealth. 2021 Jun 4;9(6):e26006
pubmed: 34085945
F1000Res. 2018 Sep 28;7:
pubmed: 30450194
J Neuroeng Rehabil. 2020 Apr 20;17(1):52
pubmed: 32312287
Sci Transl Med. 2021 Feb 3;13(579):
pubmed: 33536284
NPJ Digit Med. 2021 Mar 19;4(1):53
pubmed: 33742069
N Engl J Med. 2016 Dec 8;375(23):2293-2297
pubmed: 27959688
Nat Mach Intell. 2020 Jan;2(1):56-67
pubmed: 32607472
Clin Neuropharmacol. 2000 Mar-Apr;23(2):75-81
pubmed: 10803796
Pac Symp Biocomput. 2016;22:288-299
pubmed: 27896983
Evid Based Ment Health. 2019 Nov;22(4):153-160
pubmed: 31563865
Sensors (Basel). 2020 Oct 14;20(20):
pubmed: 33066691
NPJ Digit Med. 2018 Nov 23;1:64
pubmed: 31304341
NPJ Digit Med. 2019 Sep 25;2:95
pubmed: 31583283
J Med Internet Res. 2020 Oct 9;22(10):e19068
pubmed: 33034562
Cell Syst. 2021 Jun 16;12(6):636-653
pubmed: 34139170
Nat Commun. 2016 Aug 23;7:12460
pubmed: 27549343